Evolent Health (EVH) PT Raised to $10 at Cantor Fitzgerald on Asset Sale
Tweet Send to a Friend
Cantor Fitzgerald analyst Steven Halper raised the price target on Evolent Health (NYSE: EVH) to $10.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
